Search

Geron Corp

Chiusa

SettoreSettore sanitario

1.2 -1.64

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.2

Massimo

1.23

Metriche Chiave

By Trading Economics

Entrata

-13M

-17M

Vendite

5.6M

57M

EPS

-0.02

Margine di Profitto

-29.019

Dipendenti

258

EBITDA

-16M

-12M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+253.74% upside

Dividendi

By Acuity

Utili prossimi

4 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-44M

777M

Apertura precedente

2.84

Chiusura precedente

1.2

Geron Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 ott 2026, 22:16 UTC

Geron Corp shares are trading lower in after-market hours, retracing from an earlier session peak and remaining below their 20-day moving average.

9 ott 2026, 19:45 UTC

Geron Corp shares are trading roughly flat, showing little change since Thursday's close and positioned below its 20-day moving average.

8 ott 2026, 23:10 UTC

Geron Corp's shares advanced in after-market trading, moving higher from a low to a high since Thursday's close.

6 ott 2026, 20:07 UTC

Geron Corp's shares fell sharply, reflecting broader market volatility, and remain significantly below their 20-day moving average amid a declining trend.

5 ott 2026, 20:06 UTC

Geron Corp's shares are advancing, recovering from earlier declines and trading higher throughout the morning, though settling near the lower end of their one-month range.

1 ott 2026, 20:07 UTC

Geron Corp shares fell sharply, continuing a downward trend and remaining below their 20-day moving average, near the lower end of their one-month range.

30 set 2026, 20:07 UTC

Geron Corp's shares are advancing, having closed higher since Tuesday, despite pulling back from an earlier session peak.

29 set 2026, 23:40 UTC

Geron Corp saw notable gains in after-market trading, reaching its highest point since Tuesday's close, though still below its 20-day moving average.

28 set 2026, 20:07 UTC

Geron Corp shares fell amid a broader market downturn, influenced by declines in major tech stocks and rising geopolitical tensions, reflecting increased volatility.

25 set 2026, 19:46 UTC

Geron Corp is trading higher, having peaked earlier before retracing, though it remains below its 20-day moving average amid broader market weakness.

24 set 2026, 20:07 UTC

Geron Corp is advancing during Thursday's trading session, having peaked in the mid-afternoon, although it remains below its 20-day moving average.

23 set 2026, 22:01 UTC

In after-market trading, Geron Corp has advanced notably, moving higher since Wednesday's close, despite being 11.49% below its 20-day moving average.

22 set 2026, 22:50 UTC

Geron Corp is advancing in after-market trading, recovering from earlier declines, though it remains below its 20-day moving average.

18 set 2026, 19:36 UTC

Geron Corp shares fell sharply, continuing a decline since Thursday and trading significantly below the 20-day moving average.

17 set 2026, 23:01 UTC

Geron Corp's shares rose in after-market trading, recovering from earlier losses to reach their highest level of the day since Thursday's close.

16 set 2026, 20:10 UTC

Geron Corp's shares fell sharply, continuing a decline from Tuesday and trading near the lower end of its one-month range.

15 set 2026, 23:11 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Tuesday's close and about 11.99% below the 20-day moving average.

10 set 2026, 20:06 UTC

Geron Corp shares are lower today, continuing a trend of four consecutive sessions of declines amid a broader market downturn.

9 set 2026, 20:01 UTC

Geron Corp's shares are trading lower amid broader market declines, nearing the bottom of their one-month range and below the 20-day moving average.

8 set 2026, 20:07 UTC

Geron Corp's shares are lower today, continuing a downward trend since Friday amid broader market pressure linked to interest rate hike speculation.

3 set 2026, 20:07 UTC

Geron Corp's shares are lower during Thursday's session amid broader market declines, with no specific company news identified to explain the movement.

2 set 2026, 23:06 UTC

Geron Corp shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month trading range.

1 set 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting a positive move since Tuesday's close amid broader market fluctuations. No specific news was identified.

31 ago 2026, 23:01 UTC

Geron Corp shares are higher in after-market trading, following notable volatility. The stock's movement contrasts with recent lower closes over the past four sessions.

28 ago 2026, 19:46 UTC

Geron Corp shares are lower today, continuing a three-day decline amid ongoing inflation concerns and recent comments from Fed officials on price stability.

27 ago 2026, 23:01 UTC

Geron Corp traded roughly flat in after-market hours, remaining effectively unchanged since Thursday's close, with stability indicated by its position above the 20-day moving average.

26 ago 2026, 19:56 UTC

Geron Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains above its 20-day moving average.

25 ago 2026, 21:51 UTC

Geron Corp shares declined after market hours, reflecting broader trends amid a sharp drop in crude oil prices. The stock remains near its one-month range high.

24 ago 2026, 23:46 UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

21 ago 2026, 19:46 UTC

Geron Corp shares are lower today, reflecting broader market trends, despite remaining above the 20-day moving average and near the upper end of the one-month range.

Confronto tra pari

Modifica del prezzo

Geron Corp Previsione

Obiettivo di Prezzo

By TipRanks

253.74% in crescita

Previsioni per 12 mesi

Media 4.333 USD  253.74%

Alto 6 USD

Basso 3 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Geron Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

4 ratings

3

Acquista

1

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat